22 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 31964393 | Ternary nanocomposite carriers based on organic clay-lipid vesicles as an effective colon-targeted drug delivery system: preparation and in vitro/in vivo characterization. | 2020 Jan 21 | 2 |
2 | 31572383 | Ozone Inhalation Attenuated the Effects of Budesonide on Aspergillus fumigatus-Induced Airway Inflammation and Hyperreactivity in Mice. | 2019 | 1 |
3 | 29127842 | Budesonide facilitates weaning from mechanical ventilation in difficult-to-wean very severe COPD patients: Association with inflammatory mediators and cells. | 2018 Apr | 2 |
4 | 28217046 | Effect of nebulized budesonide on respiratory mechanics and oxygenation in acute lung injury/acute respiratory distress syndrome: Randomized controlled study. | 2017 Jan-Mar | 2 |
5 | 26996478 | Effect of Inhaled Budesonide on Interleukin-4 and Interleukin-6 in Exhaled Breath Condensate of Asthmatic Patients. | 2016 Apr 5 | 1 |
6 | 25722071 | Budesonide increases TLR4 and TLR2 expression in Treg lymphocytes of allergic asthmatics. | 2015 Jun | 2 |
7 | 24164087 | Therapeutic effect of inhaled budesonide (PulmicortĀ® Turbuhaler) on the inflammatory response to one-lung ventilation. | 2014 Jan | 1 |
8 | 24998372 | Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells. | 2014 Jul | 1 |
9 | 23617551 | Fast beneficial systemic anti-inflammatory effects of inhaled budesonide and formoterol on circulating lymphocytes in asthma. | 2013 Jul | 1 |
10 | 24062615 | Anti-inflammatory effects of budesonide in human lung fibroblast are independent of histone deacetylase 2. | 2013 | 1 |
11 | 22125636 | Budesonide and formoterol reduce early innate anti-viral immune responses in vitro. | 2011 | 2 |
12 | 20307681 | Effect of formoterol and budesonide on chemokine release, chemokine receptor expression and chemotaxis in human neutrophils. | 2010 Aug | 1 |
13 | 20388003 | Budesonide enhances Toll-like receptor 2 expression in activated bronchial epithelial cells. | 2010 May | 2 |
14 | 20729385 | Evaluation of inhaled carbon monoxide as an anti-inflammatory therapy in a nonhuman primate model of lung inflammation. | 2010 Dec | 1 |
15 | 19439980 | Inhibition of secretory phospholipase A2-induced cytokine production in human lung macrophages by budesonide. | 2009 | 1 |
16 | 18415826 | Effect of budesonide and formoterol on IL-6 and IL-8 release from primary bronchial epithelial cells. | 2008 Apr | 1 |
17 | 14692430 | The effect of budesonide on the cytokine pattern in patients with perennial allergic rhinitis. | 2003 Nov | 1 |
18 | 11392584 | Effect of budesonide and nedocromil sodium on IL-6 and IL-8 release from human nasal mucosa and polyp epithelial cells. | 2001 May | 5 |
19 | 11509812 | Inhibition of macrophage proinflammatory cytokine expression by steroids and recombinant IL-10. | 2001 Aug | 1 |
20 | 10442524 | Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages. | 1999 Jul | 2 |
21 | 8613948 | Budesonide inhibits T cell-initiated epithelial pathophysiology in an in vitro model of inflammation. | 1996 Apr | 1 |
22 | 8003851 | Effects of a corticosteroid, budesonide, on alveolar macrophage and blood monocyte secretion of cytokines: differential sensitivity of GM-CSF, IL-1 beta, and IL-6. | 1994 Feb | 1 |